 |
 |
| Agreements Completed |
- 13 new licenses/options signed
- 35 confidential disclosures signed led to 1 SBIR’s and 8 STTR’s
- Highlights include an exclusive license to a publisher for a first of its kind, “Underwater Crime Scene Investigation Manual”, a license expansion of our Tabletop Exercise System Technology (TEST) technology to the St. Petersburg College National Terrorism Preparedness Institute; and the first license as a result of the GAP Program – a license to CardioVascular BioTherapeutics for mutant fibroblast growth factor developed by FSU.
|
| Technology Development |
- 5 Work Disclosures were received
- 61 Total U.S. Patent Applications filed
- 17 US Patents issued (for details click here)
- 6 GAP Awards = $240,000
|
| FSU Income Produced |
- non Taxol royalties = $330,080
- other commercial proceeds and patent reimbursements = $2,164,119
- FY R&D commitments tied to options/licenses = $1,349,846
- Taxol Royalities = $0.00
|
| Internal FSU Workshops |
|
| New Initiatives |
- Dr. Ben Wang and his team won a Centers of Excellence Award to establish The High Performance Materials Institute
- Our Executive Director, John Fraser, served as the 2006-2007 President of AUTM, a global professional organization consisted of members from the government, Universities, and other research institutes involved in managing and licensing innovations from academic and nonprofit research.
|
|
 |
 |
Office of IP Development and Commercialization - Office of Research
2010 Levy Avenue, Suite 276-C - Tallahassee, Florida 32306-2743
Phone: (850) 644-9318 Fax: (850) 644-3675 email: jfraser@techtransfer.fsu.edu